Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Daniel

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Biological Psychiatry|November 1, 1991
Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controlsD G Daniel, T E Goldberg, R D Gibbons, et al.
Archives of General Psychiatry|December 1, 1992
Ventricular enlargement in schizophrenia: is there really a gender effect?J R Zigun, D G Daniel, J E Kleinman, et al.
Archives of General Psychiatry|December 1, 1992
Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophreniaK F Berman, E F Torrey, D G Daniel, et al.
The American Journal of Psychiatry|May 1, 1990
Left-handedness and ventricle size in schizophrenic patientsC Randolph, T E Goldberg, J Gold, et al.
Psychiatry Research|October 1, 1993
Regional cerebral blood flow during the Wisconsin Card Sorting Test in normal subjects studied by xenon-133 dynamic SPECT: comparison of absolute values, percent distribution values, and covariance analysisS Marenco, R Coppola, D G Daniel, et al.
Schizophrenia Research|November 1, 1989
The relationship of occipital skull asymmetry to brain parenchymal measures in schizophreniaD G Daniel, M S Myslobodsky, L J Ingraham, et al.
Schizophrenia Research|July 1, 1989
Shape analysis of the middle cranial fossa of schizophrenic patients. A computerized tomographic studyM F Casanova, D G Daniel, T E Goldberg, et al.
The American Journal of Psychiatry|January 1, 1991
Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophreniaT E Goldberg, L B Bigelow, D R Weinberger, et al.
Psychopharmacology|June 13, 2001
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trialD G Daniel, S G Potkin, K R Reeves, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 1999
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study GroupD G Daniel, D L Zimbroff, S G Potkin, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Biological Psychiatry|November 1, 1991
Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controlsD G Daniel, T E Goldberg, R D Gibbons, et al.
Archives of General Psychiatry|December 1, 1992
Ventricular enlargement in schizophrenia: is there really a gender effect?J R Zigun, D G Daniel, J E Kleinman, et al.
Archives of General Psychiatry|December 1, 1992
Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophreniaK F Berman, E F Torrey, D G Daniel, et al.
The American Journal of Psychiatry|May 1, 1990
Left-handedness and ventricle size in schizophrenic patientsC Randolph, T E Goldberg, J Gold, et al.
Psychiatry Research|October 1, 1993
Regional cerebral blood flow during the Wisconsin Card Sorting Test in normal subjects studied by xenon-133 dynamic SPECT: comparison of absolute values, percent distribution values, and covariance analysisS Marenco, R Coppola, D G Daniel, et al.
Schizophrenia Research|November 1, 1989
The relationship of occipital skull asymmetry to brain parenchymal measures in schizophreniaD G Daniel, M S Myslobodsky, L J Ingraham, et al.
Schizophrenia Research|July 1, 1989
Shape analysis of the middle cranial fossa of schizophrenic patients. A computerized tomographic studyM F Casanova, D G Daniel, T E Goldberg, et al.
The American Journal of Psychiatry|January 1, 1991
Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophreniaT E Goldberg, L B Bigelow, D R Weinberger, et al.
Psychopharmacology|June 13, 2001
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trialD G Daniel, S G Potkin, K R Reeves, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 1999
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study GroupD G Daniel, D L Zimbroff, S G Potkin, et al.
Pageof 6